EcoDrugPlus

Ensembl ID : ENSOMYG00000018700
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSOMYG00000018157
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000021508
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000024167
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSOMYG00000034187
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSOMYG00000037258
Gene Symbol: -
Cross references: -
333 Possible Orthologues:

Ensembl ID : ENSOMYG00000043945
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000046418
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMYG00000060048
Gene Symbol: -
Cross references: -
521 Possible Orthologues:

Ensembl ID : ENSOMYG00000060315
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSOMYG00000060335
Gene Symbol: -
Cross references: -
354 Possible Orthologues:

Ensembl ID : ENSOMYG00000060570
Gene Symbol: -
Cross references: -
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).